ASHG News - Page 2 of 72 - ASHG

ASHG News

Patient-Derived Brain Organoids Point to Personalized Treatments for Rare Epilepsies

Patient-Derived Brain Organoids Point to Personalized Treatments for Rare Epilepsies

For Immediate Release: Friday, October 23, 2026, 1:30 p.m. U.S. Eastern Time Media Contact: Evelyn Mantegani, +1 240-833-2014, [email protected] Presented By: Scott Younger, PhD, Children’s Mercy Rockville, Md. – For people with rare genetic epilepsies, finding an effective treatment can require trying multiple medications with no guarantee of success. Researchers have demonstrated an individualized approach... Read More

Beyond One Gene and One Drug: Emerging Scientists Chart Pharmacogenomics’ Multiomic Future

Beyond One Gene and One Drug: Emerging Scientists Chart Pharmacogenomics’ Multiomic Future

For Immediate Release: Friday, October 23, 2026, 8:20 a.m. U.S. Eastern Time Media Contact: Evelyn Mantegani, +1 240-833-2014, [email protected] Rockville, Md. – Pharmacogenomics is moving beyond the traditional study of individual gene-drug pairs. A trainee-led session will examine how multiomic data, functional genomics, diverse populations, biobanks, and electronic health records can provide a more complete... Read More

Personalized Genetic Therapy for Rare Form of ALS Reaches First Patient in Less Than One Year

Personalized Genetic Therapy for Rare Form of ALS Reaches First Patient in Less Than One Year

For Immediate Release: Thursday, October 22, 2026, 4:20 p.m. U.S. Eastern Time Media Contact: Evelyn Mantegani, +1 240-833-2014, [email protected] Presented By: Tamar Grossman, PhD, La Jolla Labs Rockville, Md. – Developing a therapy for a single patient is difficult under traditional drug-development models, particularly when the disease-causing genetic variant is exceptionally rare. A new program... Read More